Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,401 | 6,777 | 3,869 | 18 | 88 |
| Other current assets | 0 | 0 | 0 | 0 | 35 |
| TOTAL | $5,136 | $7,674 | $4,693 | $27 | $141 |
| Non-Current Assets | |||||
| Intangibles | 6 | 6 | 7 | 7 | 8 |
| Other Non-Current Assets | 350 | 0 | 0 | 0 | 2 |
| TOTAL | $356 | $6 | $7 | $7 | $10 |
| Total Assets | $5,491 | $7,680 | $4,699 | $35 | $152 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 649 | 190 | 100 | 342 | 20 |
| Accrued Expenses | 857 | 349 | 158 | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | 1 | 1 |
| TOTAL | $1,505 | $539 | $258 | $1,032 | $255 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,505 | $539 | $258 | $1,032 | $255 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28 | 17 | 12 | N/A | N/A |
| Common Shares | 14 | 10 | 7 | 3 | 3 |
| Retained earnings | -31,520 | -20,627 | -12,035 | -404 | -9,938 |
| TOTAL | $3,986 | $7,141 | $4,441 | $-998 | $-104 |
| Total Liabilities And Equity | $5,492 | $7,680 | $4,699 | $35 | $152 |